Showing 321 - 340 results of 1,768 for search '"growth factors"', query time: 0.12s Refine Results
  1. 321
  2. 322

    Long-Term Visual Outcomes for a Treat-and-Extend Antivascular Endothelial Growth Factor Regimen in Eyes with Neovascular Age-Related Macular Degeneration: Up to Seven-Year Follow-Up by Simon Javidi, Ali Dirani, Fares Antaki, Marc Saab, Sofiane Rahali, Ghassan Cordahi

    Published 2020-01-01
    “…To report long-term visual and anatomical outcomes in eyes with neovascular age-related macular degeneration (nAMD) treated with a treat-and-extend regimen (TER) of intravitreal antivascular endothelial growth factor (anti-VEGF) injections in real-world settings. …”
    Get full text
    Article
  3. 323

    Coregistration of Ultrasonography and Magnetic Resonance Imaging with a Preliminary Investigation of the Spatial Colocalization of Vascular Endothelial Growth Factor Receptor 2 Expression and Tumor Perfusion in a Murine Tumor Model by Mary E. Loveless, Jennifer G. Whisenant, Kevin Wilson, Andrej Lyshchik, Tuhin K. Sinha, John C. Gore, Thomas E. Yankeelov

    Published 2009-07-01
    “…In addition to anatomic images, vascular endothelial growth factor receptor 2 (VEGFR2) distribution images from the central tumor slice using VEGFR2-targeted ultrasound contrast agent (UCA) and measurements of perfusion and extravascular-extracellular volume fraction using dynamic contrast-enhanced MRI were acquired from five mice for multiparametric coregistration. …”
    Get full text
    Article
  4. 324

    Fibroblast Growth Factor-2 and the HIV-1 Tat Protein Synergize in Promoting Bcl-2 Expression and Preventing Endothelial Cell Apoptosis: Implications for the Pathogenesis of AIDS-Associated Kaposi's Sarcoma by Cecilia Sgadari, Giovanni Barillari, Clelia Palladino, Stefania Bellino, Brunella Taddeo, Elena Toschi, Barbara Ensoli

    Published 2011-01-01
    “…Our previous work indicated that the angiogenic fibroblast growth factor (FGF)-2 and the Tat protein of HIV-1, both expressed in KS lesions of HIV-infected patients, synergize at inducing angioproliferative, KS-like lesions in mice. …”
    Get full text
    Article
  5. 325
  6. 326
  7. 327
  8. 328
  9. 329
  10. 330
  11. 331

    Comparison of glycosylated fibronectin versus soluble fms-like tyrosine kinase/placental growth factor ratio testing for the assessment of pre-eclampsia: protocol for a multicentre diagnostic test accuracy study by Marcus Green, Chao Wang, Sarah Fisher, Amarnath Bhide, Ramesh Ganapathy, Basky Thilaganathan, Nouran Elbarbary

    Published 2025-02-01
    “…The prediction of pre-eclampsia in high-risk populations using angiogenic markers, such as serum placental growth factor (PlGF) assessment, has been shown to improve maternal outcomes and is recommended by the National Institute for Health and Care Excellence (NICE). …”
    Get full text
    Article
  12. 332
  13. 333

    A potential innovative surrogate marker for hypoxic injury: Shehata marker of angiogenesis by Shehata A. Mohamed

    Published 2025-01-01
    Subjects: “…vascular endothelial growth factor…”
    Get full text
    Article
  14. 334
  15. 335
  16. 336
  17. 337
  18. 338
  19. 339
  20. 340